Article
Multiplex gene-panel testing for lung cancer patients.
Pathology international - 1 Dec 2020
Yatabe Yasushi, Sunami Kuniko, Goto Koichi, Nishio Kazuto, Aragane Naoko, Ikeda Sadakatsu, Inoue Akira, Kinoshita Ichiro, Kimura Hideharu, Sakamoto Tomohiro, Satouchi Miyako, Shimizu Junichi, Tsuta Koji, Toyooka Shinichi, Nishino Kazumi, Hatanaka Yutaka, Matsumoto Shingo, Mikubo Masashi, Yokose Tomoyuki, Dosaka-Akita Hirotoshi
Abstract excerpt
The year 2019 was considered to be the first year of cancer genome medicine in Japan, with three gene-panel tests using next-generation sequencing (NGS) techniques being introduced into clinical practice. Among the three tests, the Oncomine CDx Target test was approved under the category of regular molecular testing for lung cancer, which meant that this test could be used to select patients for molecularly...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.